Conduit Pharmaceuticals (NYSE: CDT) — Perfil da empresa, notícias e dados financeiros
Conduit Pharmaceuticals is a clinical-stage biopharmaceutical firm developing drugs for unmet medical needs in San Diego.
CDT Conduit Pharmaceuticals
Perfil da empresa
Conduit Pharmaceuticals
Conduit Pharmaceuticals (NASDAQ:CDT) is a clinical-stage biopharmaceutical company focusing on developing drugs for unmet medical needs. They prioritize assets overlooked by larger companies. Their pipeline includes a drug in Phase II for autoimmune diseases and a potential treatment for male infertility. The company is headquartered in San Diego, California.
Resumo
Public USParticipação acionária
2019Ano de fundação
4Funcionários
San Diego, United StatesSede
Carregando mapa...
Presença global
Operações
Todos os locais
United States
Produtos e/ou serviços de Conduit Pharmaceuticals
- Drug Development: Conduit identifies promising drug candidates with the potential to address unmet medical needs.
- Clinical Trials: They design and conduct clinical trials to test the safety and efficacy of their drug candidates.
- Partnerships: Conduit may collaborate with other pharmaceutical companies to develop and commercialize their drugs.
- Autoimmune Disease Treatments: Their current pipeline prioritizes drugs for autoimmune diseases like uveitis and Hashimoto's Thyroiditis.
- Male Infertility Treatment: They're also exploring treatments for idiopathic male infertility.
- Licensing: Conduit might license their developed drugs to other companies for further development or commercialization.
equipe executiva do Conduit Pharmaceuticals
- James BlighCo-Founder, CEO & Director
- Joanne M. HollandChief Scientific Officer
- David Joszef TapolczayHead of Strategy & Licensing
Principais indicadores financeiros
Resultados divulgados pela Conduit Pharmaceuticals, em USD.
- Cap. de mercado
- 316 mil
- Receita (TTM)
- 0
- P/L
- 0.0
- LPA (diluído, TTM)
- 90812.5
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2,7 bi | -36,8 mi | -39,2 mi | |
| 922,2 mi | -15,4 mi | -17,8 mi | |
| 0 | -5,3 mi | -535 mil | |
| 0 | -3,2 mi | -4,9 mi |